CJC-1295 with DAC

FDA APPROVAL PENDING

Well Studied

Weight

Growth

CJC-1295 with DAC

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

Learn more

Weight

CJC-1295 with DAC

Growth

Amino acid sequence

29

Amino acids

3367.9da

Molecular weight

Peptide

Type

Modified growth hormone releasing hormone engineered for extended duration via albumin-binding technology. DAC binds to albumin, extending half-life and providing continuous GHRH receptor stimulation.

Top researched benefits

Overview of CJC-1295 with DAC

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation.

growth hormone

  • Continuous growth hormone release for 6-8 days per injection.
  • Significantly elevates IGF-1 levels for extended periods.
  • Weekly dosing ideal for simple administration.

body composition

  • Continuous GH elevation promotes lipolysis and fat metabolism.
  • Sustained anabolic environment supports muscle protein synthesis.

antiaging

  • Accelerated healing and recovery from exercise or injury.

Typical Dose

1-2mg weekly

Frequency

Once or twice weekly (e.g., Monday/Thursday for split dosing)

Cycle Duration

8-12 weeks

Storage

Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated, use within 30 days

Chemical Makeup

Key benefits

Convenient weekly dosing

Sustained GH/IGF-1 elevation

6-8 day half-life

Significant body composition changes

Community interest

This peptide is still gaining traction in the community.

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

CJC-1295 with DAC Molecular Information

View the scientifc details of CJC-1295 with DAC.

29

Amino Acids

CJC-1295 with DAC

Tyr

Tyr

Position 1

Ala

Ala

Position 2

Asp

Asp

Position 3

Ala

Ala

Position 4

Ile

Ile

Position 5

Phe

Phe

Position 6

Thr

Thr

Position 7

Gln

Gln

Position 8

Ser

Ser

Position 9

Tyr

Tyr

Position 10

Arg

Arg

Position 11

Lys

Lys

Position 12

Val

Val

Position 13

Leu

Leu

Position 14

Ala

Ala

Position 15

Gln

Gln

Position 16

Leu

Leu

Position 17

Ser

Ser

Position 18

Ala

Ala

Position 19

Arg

Arg

Position 20

Lys

Lys

Position 21

Leu

Leu

Position 22

Leu

Leu

Position 23

Gln

Gln

Position 24

Asp

Asp

Position 25

Ile

Ile

Position 26

Leu

Leu

Position 27

Ser

Ser

Position 28

Arg

Arg

Position 29

Amino acid sequence
TyrosinePosition 1
AlaninePosition 2
Aspartic acidPosition 3
AlaninePosition 4
IsoleucinePosition 5
PhenylalaninePosition 6
ThreoninePosition 7
GlutaminePosition 8
SerinePosition 9
TyrosinePosition 10
ArgininePosition 11
LysinePosition 12
ValinePosition 13
LeucinePosition 14
AlaninePosition 15
GlutaminePosition 16
LeucinePosition 17
SerinePosition 18
AlaninePosition 19
ArgininePosition 20
LysinePosition 21
LeucinePosition 22
LeucinePosition 23
GlutaminePosition 24
Aspartic acidPosition 25
IsoleucinePosition 26
LeucinePosition 27
SerinePosition 28
ArgininePosition 29

Molecular Weight

3367.9Da

Chain Length

29Amino Acids

Type

Peptide

CJC-1295 with DAC Protocols

Subcutaneous injection is the preferred route for DAC variant.

GoalDosageFrequencyRoute
Conservative Anti-Aging11 week rangeSubQ
Standard Protocol21 week rangeSubQ
Split Dosing12 week rangeSubQ
Loading Protocol2SubQ

Reconstitution Instructions

Materials needed:

CJC-1295 with DAC peptide vialBacteriostatic water (2-5mL)Insulin or 1mL syringesAlcohol prep pads

Steps to reconstitute

  1. Clean both vial tops with alcohol and dry completely
  2. 2mg vial: Add 1mL bacteriostatic water (creates 2mg/mL)
  3. 5mg vial: Add 2.5mL bacteriostatic water (creates 2mg/mL)
  4. Inject water slowly to prevent foaming
  5. Let sit 5 minutes before gently rolling to mix
  6. Solution may appear slightly cloudy initially
  7. Label with date and concentration immediately

CJC-1295 with DAC Cycle

The CJC-1295 with DAC Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 0-0
Possible water retention, improved sleep, increased appetite
Week 2-3
Noticeable recovery improvements, some report joint discomfort
Week 4-6
Visible body composition changes, increased vascularity
Week 6-8
Continued improvements but watch for desensitization signs
Week 0-0
Most gains maintained; IGF-1 returns to baseline in 2-3 weeks

Dosing tools

CJC-1295 with DAC Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

mg

Enter the total amount of peptide in the vial in milligrams (as stated on the label).

The dose you want to inject per administration, in mcg or mg.

1,000 mcg = 1 mg

1 mL

2 mL

3 mL

5 mL

Custom

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

Injection Results

Based on your vial and dilution inputs.

CJC-1295 with DAC

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg CJC-1295 with DAC vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

1mL / 100 units

5 units

0.050 mL

Reference Guide

Dosing Cycle

Peptide
CJC-1295 with DAC
Dosing
1-2mg weekly
Dosing Frequency
Once or twice weekly (e.g., Monday/Thursday for split dosing)
Cycle Duration
8-12 weeks
Storage
Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated, use within 30 days

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of CJC-1295 with DAC interactions with other common peptides and substances.

Weight

cjc

Growth

CJC-1295 (without DAC)

AVOID

Never combine different variants; choose based on desired release pattern.

AVOID

Weight

ghrp

Growth

GHRP-6

MONITOR

GHRP pulse effects diminished with continuous GH elevation.

MONITOR

Weight

hgh

Growth

HGH

AVOID

Defeats purpose and may suppress natural production.

AVOID

Weight

ipa

Growth

Ipamorelin

MONITOR

Continuous GH elevation may reduce synergistic benefits of pulsatile protocols.

MONITOR

Weight

mk6

Growth

MK-677

AVOID

Both provide continuous GH elevation; combination risks excessive levels.

AVOID

Weight

ser

Growth

Sermorelin

MONITOR

CJC-1295 DAC is already more potent and long-lasting.

MONITOR

Weight

tesa

Growth

Tesamorelin

AVOID

Both are GHRH analogs; no additional benefit and potential receptor competition.

AVOID

Side effects

Avoid: Do not take CJC-1295 with DAC with CJC-1295 (without DAC), HGH, MK-677, Tesamorelin.

Monitor: Be careful when combining CJC-1295 with DAC with GHRP-6, Ipamorelin, Sermorelin.

Contraindications

Diabetes history

Cancer history

Predisposed sleep apnea

Stop signs

Severe joint pain or carpal tunnel syndrome

Excessive water retention affecting daily life

Numbness or tingling in extremities

Significant blood glucose dysregulation

Signs of acromegaly (jaw growth, hand/feet enlargement)

Persistent lethargy indicating adrenal effects

Bad signs

Extremely cheap pricing (if priced similar to non-DAC, likely mislabeled)Clear solution immediately (should be slightly cloudy initially)
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

CJC-1295 with DACResearch References

CJC-1295 with DAC is a well studied compound

4Research references

CJC-1295 with DAC

CJC-1295 with DAC is a well studied compound

Prolonged Growth Hormone Elevation with CJC-1295 DAC

12 subjects; sustained GH and IGF-1 elevation for 6-10 days post-injection with peak 2-4x baseline.

2006

Dose-Response Relationship of CJC-1295 DAC

48 subjects, 90 days. Optimal dosing 1-2mg weekly; dose-dependent IGF-1 increases but higher side effects above 2mg.

2008

Long-term Effects on GH/IGF-1 Axis

6-month animal model. Sustained IGF-1 elevation but evidence of reduced GH pulse amplitude suggesting desensitization.

2012

Comparative Pharmacokinetics: DAC vs Non-DAC Variants

DAC: 120-hour half-life vs non-DAC: 30-minute; non-DAC preserves more physiological patterns.

2015